Homology Medicines Inc FIXX

$14.15 +13.21 (1,413.65%)

Valuation

Market cap
54,338,000
Revenue TTM
$1,160,000
Net income TTM
$-112,960,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-9,737.93%
Debt to equity
0.00

Trading

Volume
2,400
Avg volume
—
Day's range
$13.79 – $14.15
Shares out
58,134,000
Stochastic %K
—
Beta
-0.10
Analysts
Hold
Price target
$4.25

Price

Company profile

The fund invests at least 80% of its net assets (plus borrowings for investment purposes) in the underlying security and financial instruments with economic characteristics that, in combination, provide 200% leveraged exposure to the price of the underlying security, on a daily basis, consistent with the fund’s investment objective. It is non-diversified.

Latest news

No headlines yet.